Royalty Pharma (RPRX)
NASDAQ: RPRX
· Real-Time Price · USD
36.07
-0.42 (-1.15%)
At close: Oct 03, 2025, 3:59 PM
36.00
-0.19%
After-hours: Oct 03, 2025, 06:22 PM EDT
Royalty Pharma Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for RPRX stock have an median target of 42, with a low estimate of 42 and a high estimate of 54. The median target predicts an increase of 16.44% from the current stock price of 36.07.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 42 | 46 | 42 | 54 |
| Change | 16.44% | 27.53% | 16.44% | 49.71% |
Latest Analyst Insight Report
According to 3 stock analyst, the rating for Royalty Pharma is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
| Rating | Oct 24 | Jul 25 | Sep 25 |
|---|---|---|---|
| Strong Buy | 0 | 1 | 0 |
| Buy | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 2 | 1 |
Financial Forecast this Year
Revenue This Year
2.94B
from 2.26B
Increased by 29.9%
Revenue Next Year
3.1B
from 2.94B
Increased by 5.3%
EPS This Year
4.48
from 1.93
Increased by 132.1%
EPS Next Year
4.8
from 4.48
Increased by 7.1%